A detailed history of Simplex Trading, LLC transactions in Exagen Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 554 shares of XGN stock, worth $3,058. This represents 0.0% of its overall portfolio holdings.

Number of Shares
554
Previous 634 12.62%
Holding current value
$3,058
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$1.74 - $3.42 $139 - $273
-80 Reduced 12.62%
554 $1,000
Q2 2024

Jul 25, 2024

BUY
$1.36 - $2.05 $862 - $1,299
634 New
634 $1,000
Q1 2023

Apr 27, 2023

SELL
$2.23 - $2.9 $695 - $904
-312 Reduced 57.04%
235 $0
Q4 2022

Feb 02, 2023

BUY
$2.1 - $3.4 $1,148 - $1,859
547 New
547 $1,000
Q1 2022

May 02, 2022

SELL
$7.12 - $11.06 $85 - $132
-12 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$8.97 - $14.08 $107 - $168
12 New
12 $0

Others Institutions Holding XGN

About EXAGEN INC.


  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $89.8M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.